table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global Prophylactic Human Vaccines Market Size Analysis from 2023 to 2030
1.5.1 Global Prophylactic Human Vaccines Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global Prophylactic Human Vaccines Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global Prophylactic Human Vaccines Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: Prophylactic Human Vaccines Industry Impact
Chapter 2 Global Prophylactic Human Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Prophylactic Human Vaccines (Volume and Value) by Type
2.1.1 Global Prophylactic Human Vaccines Consumption and Market Share by Type (2017-2022)
2.1.2 Global Prophylactic Human Vaccines Revenue and Market Share by Type (2017-2022)
2.2 Global Prophylactic Human Vaccines (Volume and Value) by Application
2.2.1 Global Prophylactic Human Vaccines Consumption and Market Share by Application (2017-2022)
2.2.2 Global Prophylactic Human Vaccines Revenue and Market Share by Application (2017-2022)
2.3 Global Prophylactic Human Vaccines (Volume and Value) by Regions
2.3.1 Global Prophylactic Human Vaccines Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Prophylactic Human Vaccines Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Prophylactic Human Vaccines Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Prophylactic Human Vaccines Consumption by Regions (2017-2022)
4.2 North America Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
4.10 South America Prophylactic Human Vaccines Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Prophylactic Human Vaccines Market Analysis
5.1 North America Prophylactic Human Vaccines Consumption and Value Analysis
5.1.1 North America Prophylactic Human Vaccines Market Under COVID-19
5.2 North America Prophylactic Human Vaccines Consumption Volume by Types
5.3 North America Prophylactic Human Vaccines Consumption Structure by Application
5.4 North America Prophylactic Human Vaccines Consumption by Top Countries
5.4.1 United States Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
5.4.2 Canada Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
5.4.3 Mexico Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 6 East Asia Prophylactic Human Vaccines Market Analysis
6.1 East Asia Prophylactic Human Vaccines Consumption and Value Analysis
6.1.1 East Asia Prophylactic Human Vaccines Market Under COVID-19
6.2 East Asia Prophylactic Human Vaccines Consumption Volume by Types
6.3 East Asia Prophylactic Human Vaccines Consumption Structure by Application
6.4 East Asia Prophylactic Human Vaccines Consumption by Top Countries
6.4.1 China Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
6.4.2 Japan Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
6.4.3 South Korea Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 7 Europe Prophylactic Human Vaccines Market Analysis
7.1 Europe Prophylactic Human Vaccines Consumption and Value Analysis
7.1.1 Europe Prophylactic Human Vaccines Market Under COVID-19
7.2 Europe Prophylactic Human Vaccines Consumption Volume by Types
7.3 Europe Prophylactic Human Vaccines Consumption Structure by Application
7.4 Europe Prophylactic Human Vaccines Consumption by Top Countries
7.4.1 Germany Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.2 UK Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.3 France Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.4 Italy Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.5 Russia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.6 Spain Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.7 Netherlands Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.8 Switzerland Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
7.4.9 Poland Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 8 South Asia Prophylactic Human Vaccines Market Analysis
8.1 South Asia Prophylactic Human Vaccines Consumption and Value Analysis
8.1.1 South Asia Prophylactic Human Vaccines Market Under COVID-19
8.2 South Asia Prophylactic Human Vaccines Consumption Volume by Types
8.3 South Asia Prophylactic Human Vaccines Consumption Structure by Application
8.4 South Asia Prophylactic Human Vaccines Consumption by Top Countries
8.4.1 India Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
8.4.2 Pakistan Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Prophylactic Human Vaccines Market Analysis
9.1 Southeast Asia Prophylactic Human Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Prophylactic Human Vaccines Market Under COVID-19
9.2 Southeast Asia Prophylactic Human Vaccines Consumption Volume by Types
9.3 Southeast Asia Prophylactic Human Vaccines Consumption Structure by Application
9.4 Southeast Asia Prophylactic Human Vaccines Consumption by Top Countries
9.4.1 Indonesia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.2 Thailand Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.3 Singapore Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.4 Malaysia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.5 Philippines Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.6 Vietnam Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
9.4.7 Myanmar Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 10 Middle East Prophylactic Human Vaccines Market Analysis
10.1 Middle East Prophylactic Human Vaccines Consumption and Value Analysis
10.1.1 Middle East Prophylactic Human Vaccines Market Under COVID-19
10.2 Middle East Prophylactic Human Vaccines Consumption Volume by Types
10.3 Middle East Prophylactic Human Vaccines Consumption Structure by Application
10.4 Middle East Prophylactic Human Vaccines Consumption by Top Countries
10.4.1 Turkey Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.3 Iran Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.5 Israel Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.6 Iraq Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.7 Qatar Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.8 Kuwait Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
10.4.9 Oman Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 11 Africa Prophylactic Human Vaccines Market Analysis
11.1 Africa Prophylactic Human Vaccines Consumption and Value Analysis
11.1.1 Africa Prophylactic Human Vaccines Market Under COVID-19
11.2 Africa Prophylactic Human Vaccines Consumption Volume by Types
11.3 Africa Prophylactic Human Vaccines Consumption Structure by Application
11.4 Africa Prophylactic Human Vaccines Consumption by Top Countries
11.4.1 Nigeria Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
11.4.2 South Africa Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
11.4.3 Egypt Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
11.4.4 Algeria Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
11.4.5 Morocco Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 12 Oceania Prophylactic Human Vaccines Market Analysis
12.1 Oceania Prophylactic Human Vaccines Consumption and Value Analysis
12.2 Oceania Prophylactic Human Vaccines Consumption Volume by Types
12.3 Oceania Prophylactic Human Vaccines Consumption Structure by Application
12.4 Oceania Prophylactic Human Vaccines Consumption by Top Countries
12.4.1 Australia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
12.4.2 New Zealand Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 13 South America Prophylactic Human Vaccines Market Analysis
13.1 South America Prophylactic Human Vaccines Consumption and Value Analysis
13.1.1 South America Prophylactic Human Vaccines Market Under COVID-19
13.2 South America Prophylactic Human Vaccines Consumption Volume by Types
13.3 South America Prophylactic Human Vaccines Consumption Structure by Application
13.4 South America Prophylactic Human Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.2 Argentina Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.3 Columbia Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.4 Chile Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.5 Venezuela Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.6 Peru Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
13.4.8 Ecuador Prophylactic Human Vaccines Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Prophylactic Human Vaccines Business
14.1 ALK
14.1.1 ALK Company Profile
14.1.2 ALK Prophylactic Human Vaccines Product Specification
14.1.3 ALK Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Altimmune
14.2.1 Altimmune Company Profile
14.2.2 Altimmune Prophylactic Human Vaccines Product Specification
14.2.3 Altimmune Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bavarian Nordic
14.3.1 Bavarian Nordic Company Profile
14.3.2 Bavarian Nordic Prophylactic Human Vaccines Product Specification
14.3.3 Bavarian Nordic Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 BiondVax Pharmaceuticals
14.4.1 BiondVax Pharmaceuticals Company Profile
14.4.2 BiondVax Pharmaceuticals Prophylactic Human Vaccines Product Specification
14.4.3 BiondVax Pharmaceuticals Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Bharat Biotech International
14.5.1 Bharat Biotech International Company Profile
14.5.2 Bharat Biotech International Prophylactic Human Vaccines Product Specification
14.5.3 Bharat Biotech International Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profile
14.6.2 GlaxoSmithKline Prophylactic Human Vaccines Product Specification
14.6.3 GlaxoSmithKline Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Hualan Biological Engineering
14.7.1 Hualan Biological Engineering Company Profile
14.7.2 Hualan Biological Engineering Prophylactic Human Vaccines Product Specification
14.7.3 Hualan Biological Engineering Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Janssen Pharmaceuticals
14.8.1 Janssen Pharmaceuticals Company Profile
14.8.2 Janssen Pharmaceuticals Prophylactic Human Vaccines Product Specification
14.8.3 Janssen Pharmaceuticals Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 MedImmune
14.9.1 MedImmune Company Profile
14.9.2 MedImmune Prophylactic Human Vaccines Product Specification
14.9.3 MedImmune Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Merck
14.10.1 Merck Company Profile
14.10.2 Merck Prophylactic Human Vaccines Product Specification
14.10.3 Merck Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Pfizer
14.11.1 Pfizer Company Profile
14.11.2 Pfizer Prophylactic Human Vaccines Product Specification
14.11.3 Pfizer Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Sanofi Pasteur
14.12.1 Sanofi Pasteur Company Profile
14.12.2 Sanofi Pasteur Prophylactic Human Vaccines Product Specification
14.12.3 Sanofi Pasteur Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Serum Institute of India
14.13.1 Serum Institute of India Company Profile
14.13.2 Serum Institute of India Prophylactic Human Vaccines Product Specification
14.13.3 Serum Institute of India Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Shanghai BravoBio
14.14.1 Shanghai BravoBio Company Profile
14.14.2 Shanghai BravoBio Prophylactic Human Vaccines Product Specification
14.14.3 Shanghai BravoBio Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Seqirus
14.15.1 Seqirus Company Profile
14.15.2 Seqirus Prophylactic Human Vaccines Product Specification
14.15.3 Seqirus Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 SK Chemicals
14.16.1 SK Chemicals Company Profile
14.16.2 SK Chemicals Prophylactic Human Vaccines Product Specification
14.16.3 SK Chemicals Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Takeda Pharmaceutical Company
14.17.1 Takeda Pharmaceutical Company Company Profile
14.17.2 Takeda Pharmaceutical Company Prophylactic Human Vaccines Product Specification
14.17.3 Takeda Pharmaceutical Company Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Zydus Cadila
14.18.1 Zydus Cadila Company Profile
14.18.2 Zydus Cadila Prophylactic Human Vaccines Product Specification
14.18.3 Zydus Cadila Prophylactic Human Vaccines Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Prophylactic Human Vaccines Market Forecast (2023-2030)
15.1 Global Prophylactic Human Vaccines Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global Prophylactic Human Vaccines Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global Prophylactic Human Vaccines Value and Growth Rate Forecast (2023-2030)
15.2 Global Prophylactic Human Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global Prophylactic Human Vaccines Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global Prophylactic Human Vaccines Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America Prophylactic Human Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global Prophylactic Human Vaccines Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global Prophylactic Human Vaccines Consumption Forecast by Type (2023-2030)
15.3.2 Global Prophylactic Human Vaccines Revenue Forecast by Type (2023-2030)
15.3.3 Global Prophylactic Human Vaccines Price Forecast by Type (2023-2030)
15.4 Global Prophylactic Human Vaccines Consumption Volume Forecast by Application (2023-2030)
15.5 Prophylactic Human Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
